What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Cytokine
Thomas M. Kündig mostly deals with Immunology, Cytotoxic T cell, Antigen, Immune system and Molecular biology.
His study in Allergen, Allergy, Vaccination, Adjuvant and Immunotherapy are all subfields of Immunology.
Thomas M. Kündig combines subjects such as T lymphocyte and CD8 with his study of Cytotoxic T cell.
His Antigen research is multidisciplinary, incorporating elements of Virus and Receptor.
The various areas that Thomas M. Kündig examines in his Immune system study include Lymph node and Antibody, B cell.
His research in Molecular biology intersects with topics in T cell and Thymocyte.
His most cited work include:
- Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. (1605 citations)
- Differential T cell costimulatory requirements in CD28-deficient mice (1186 citations)
- Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta (775 citations)
What are the main themes of his work throughout his whole career to date?
Thomas M. Kündig focuses on Immunology, Antigen, Immune system, Cytotoxic T cell and Immunotherapy.
Allergy, Allergen, Vaccination, T cell and Adjuvant are the core of his Immunology study.
His research integrates issues of Molecular biology and B cell in his study of T cell.
His Antigen research incorporates elements of Virus, Antibody and Antigen presentation.
The study incorporates disciplines such as Lymph node and Cell biology in addition to Immune system.
His Cytotoxic T cell study incorporates themes from T lymphocyte, CD8 and Virology.
He most often published in these fields:
- Immunology (59.75%)
- Antigen (25.42%)
- Immune system (25.42%)
What were the highlights of his more recent work (between 2017-2021)?
- Immunology (59.75%)
- Immune system (25.42%)
- Vaccination (10.59%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Immune system, Vaccination, Adjuvant and Allergen.
Immunology and Dermatology are frequently intertwined in his study.
His work in the fields of Immunogenicity, T cell and Acquired immune system overlaps with other areas such as Cancer cell lines.
His study looks at the intersection of T cell and topics like Cytotoxic T cell with Cancer research.
Thomas M. Kündig has included themes like Inflammation, Inflammasome, Antigen, Disease and Allergen immunotherapy in his Adjuvant study.
His research in Allergen tackles topics such as Immunotherapy which are related to areas like Grass pollen and Clinical evidence.
Between 2017 and 2021, his most popular works were:
- Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients. (47 citations)
- PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer. (38 citations)
- Treating insect-bite hypersensitivity in horses with active vaccination against IL-5. (34 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Cytokine
Thomas M. Kündig mainly investigates Immunology, Vaccination, Adjuvant, Immune system and Allergen.
His biological study spans a wide range of topics, including Allergic response, Eosinophil and Lesion.
His research in Immunogenicity and T cell are components of Immune system.
In Immunogenicity, Thomas M. Kündig works on issues like Cytotoxic T cell, which are connected to Cancer research.
His T cell research incorporates themes from Allergen immunotherapy, Immunoglobulin E and Cytokine secretion.
His work in Allergen tackles topics such as Immunotherapy which are related to areas like Subcutaneous injection, Gold standard, Clinical evidence and Dermatology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
